Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 581795, 14 pages
http://dx.doi.org/10.1155/2014/581795
Review Article

Oral Complications and Management Strategies for Patients Undergoing Cancer Therapy

1Faculty of Dentistry, The University of Hong Kong, Hong Kong
2The Prince Philip Dental Hospital, 34 Hospital Road, Hong Kong

Received 4 September 2013; Accepted 19 December 2013; Published 8 January 2014

Academic Editors: T. Castroflorio and S. R. Fidel

Copyright © 2014 Hai Ming Wong. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Centers for Disease Controland Prevention, “Ttop ten cancers,” 2009, http://apps.nccd.cdc.gov/uscs/toptencancers.aspx.
  2. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2012,” CA—A Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. American Cancer Society, “Cancer Facts & Figures,” 2013, http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf.
  4. D. D. Mosel, R. L. Bauer, D. P. Lynch, and S. T. Hwang, “Oral complications in the treatment of cancer patients,” Oral Diseases, vol. 17, no. 6, pp. 550–559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. V. K. Joshi, “Dental treatment planning and management for the mouth cancer patient,” Oral Oncology, vol. 46, no. 6, pp. 475–479, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. H. L. Hong, J. J. Napeñas, B. D. Hodgson et al., “A systematic review of dental disease in patients undergoing cancer therapy,” Supportive Care in Cancer, vol. 18, no. 8, pp. 1007–1021, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. S. Chambers, B. B. Toth, J. W. Martin, T. J. Fleming, and J. C. Lemon, “Oral and dental management of the cancer patient: prevention and treatment of complications,” Supportive Care in Cancer, vol. 3, no. 3, pp. 168–175, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Miller and N. Kearney, “Oral care for patients with cancer: a review of the literature,” Cancer Nursing, vol. 24, no. 4, pp. 241–254, 2001. View at Google Scholar · View at Scopus
  9. G. J. Barker, J. B. Epstein, K. B. Williams, M. Gorsky, and J. E. Raber-Durlacher, “Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers,” Supportive Care in Cancer, vol. 13, no. 1, pp. 32–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Al-Dakkak, “The association between cancer treatments and oral diseases,” Evidence-Based Dentistry, vol. 12, no. 1, pp. 15–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kolokythas, “Long-term surgical complications in the oral cancer patient: a comprehensive review. Part I,” Journal of Oral & Maxillofacial Research, vol. 1, no. 3, article e1, 2010. View at Google Scholar
  12. I. Carreca, L. Balducci, and M. Extermann, “Cancer in the older person,” Cancer Treatment Reviews, vol. 31, no. 5, pp. 380–402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. B. C. López, C. G. Esteve, and M. G. S. Pérez, “Dental treatment considerations in the chemotherapy patient,” Journal of Clinical and Experimental Dentistry, vol. 3, pp. e31–e42, 2011. View at Google Scholar
  14. N. Toscano, D. Holtzclaw, I. A. Hargitai et al., “Oral implications of cancer chemotherapy,” The Journal of Implant & Advanced Clinical Dentistry, vol. 1, pp. 51–69, 2009. View at Google Scholar
  15. M. P. López Galindo, J. V. Bagán, Y. Jiménez Soriano, F. Alpiste, and C. Camps, “Clinical evaluation of dental and periodontal status in a group of oncological patients before chemotherapy,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 11, no. 1, pp. 17–21, 2006. View at Google Scholar · View at Scopus
  16. F. Caribé Gomes, E. Chimenos Küstner, J. López López, F. Finestres Zubeldia, and B. Guix Melcior, “Dental management of the complications of radio and chemotherapy in oral cancer,” Medicina Oral, vol. 8, no. 3, pp. 178–187, 2003. View at Google Scholar · View at Scopus
  17. A. Vissink, J. Jansma, F. K. L. Spijkervet, F. R. Burlage, and R. P. Coppes, “Oral sequelae of head and neck radiotherapy,” Critical Reviews in Oral Biology and Medicine, vol. 14, no. 3, pp. 199–212, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. A. C. Begg, F. A. Stewart, and C. Vens, “Strategies to improve radiotherapy with targeted drugs,” Nature Reviews Cancer, vol. 11, no. 4, pp. 239–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Bourhis, A. Etessami, and A. Lusinchi, “New trends in radiotherapy for head and neck cancer,” Annals of Oncology, vol. 16, no. 2, pp. ii255–ii257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Kielbassa, W. Hinkelbein, E. Hellwig, and H. Meyer-Lückel, “Radiation-related damage to dentition,” The Lancet Oncology, vol. 7, no. 4, pp. 326–335, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. E. A. Copelan, “Hematopoietic stem-cell transplantation,” The New England Journal of Medicine, vol. 354, no. 17, pp. 1813–1826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Yamagata, K. Onizawa, T. Yanagawa et al., “A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation,” Bone Marrow Transplantation, vol. 38, no. 3, pp. 237–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Toth and T. J. Fleming, “Oral care for the patient with cancer,” Highlights Antineoplastic Drugs, vol. 8, pp. 27–35, 1990. View at Google Scholar
  24. B. Toth, J. W. Martin, and T. J. Fleming, “Oral and dental care associated with cancer therapy,” Cancer Bulletin, vol. 43, pp. 397–402, 1991. View at Google Scholar
  25. A. Kolokythas, “Long-term surgical complications in the oral cancer patient: a comprehensive review. part II,” Journal of Oral & Maxillofacial Research, vol. 1, article e2, 2010. View at Google Scholar
  26. G. R. LaBlance, K. Kraus, and K. F. Steckol, “Rehabilitation of swallowing and communication following glossectomy,” Rehabilitation Nursing, vol. 16, no. 5, pp. 266–270, 1991. View at Google Scholar · View at Scopus
  27. R. Massengill Jr., S. Maxwell, and K. Pickrell, “An analysis of articulation following partial and total glossectomy,” Journal of Speech and Hearing Disorders, vol. 35, no. 2, pp. 170–173, 1970. View at Google Scholar · View at Scopus
  28. B. R. Pauloski, J. A. Logemann, L. A. Colangelo et al., “Surgical variables affecting speech in treated patients with oral and oropharyngeal cancer,” Laryngoscope, vol. 108, no. 6, pp. 908–916, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Roa Pauloski, J. A. Logemann, A. W. Rademaker et al., “Speech and swallowing function after anterior tongue and floor of mouth resection with distal flap reconstruction,” Journal of Speech and Hearing Research, vol. 36, no. 2, pp. 267–276, 1993. View at Google Scholar · View at Scopus
  30. A. Kolokythas, “Long-term surgical complications in the oral cancer patient: a comprehensive review. Part I,” Journal of Oral and Maxillofacial Surgery, vol. 1, article e1, 2010. View at Google Scholar
  31. M. L. Urken, D. Buchbinder, H. Weinberg et al., “Functional evaluation following microvascular oromandibular reconstruction of the oral cancer patient: a comparative study of reconstructed and nonreconstructed patients,” Laryngoscope, vol. 101, no. 9, pp. 935–950, 1991. View at Google Scholar · View at Scopus
  32. D. A. Curtis, O. Plesh, A. J. Miller et al., “A comparison of masticatory function in patients with or without reconstruction of the mandible,” Head and Neck, vol. 19, no. 4, pp. 287–296, 1997. View at Google Scholar · View at Scopus
  33. C. J. Kerawala, “Complications of head and neck cancer surgery—prevention and management,” Oral Oncology, vol. 46, no. 6, pp. 433–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. D. Kim and R. A. Ord, “Complications in the treatment of head and neck cancer,” Oral and Maxillofacial Surgery Clinics of North America, vol. 15, no. 2, pp. 213–227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. E. B. Neovius, M. G. Lind, and F. G. Lind, “Hyperbaric oxygen therapy for wound complications after surgery in the irradiated head and neck: a review of the literature and a report of 15 consecutive patients,” Head and Neck, vol. 19, no. 4, pp. 315–322, 1997. View at Google Scholar · View at Scopus
  36. N. Treister and S. Sonis, “Mucositis: biology and management,” Current Opinion in Otolaryngology and Head and Neck Surgery, vol. 15, no. 2, pp. 123–129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. C. H. Hong and M. daFonseca, “Considerations in the pediatric population with cancer,” Dental Clinics of North America, vol. 52, no. 1, pp. 155–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Borbasi, K. Cameron, B. Quested, I. Olver, B. To, and D. Evans, “More than a sore mouth: patients' experience of oral mucositis,” Oncology Nursing Forum, vol. 29, no. 7, pp. 1051–1057, 2002. View at Google Scholar · View at Scopus
  39. J. C. Murray, J. K. H. Chiu, S. R. Dorfman, and A. K. Ogden, “Epiglottitis following preparation for allogeneic bone marrow transplantation,” Bone Marrow Transplantation, vol. 15, no. 6, pp. 997–998, 1995. View at Google Scholar · View at Scopus
  40. S. T. Sonis, “A biological approach to mucositis,” Journal of Supportive Oncology, vol. 2, no. 1, pp. 21–32, 2004. View at Google Scholar · View at Scopus
  41. K. H. Chaimberg and J. P. Cravero, “Mucositis and airway obstruction in a pediatric patient,” Anesthesia and Analgesia, vol. 99, no. 1, pp. 59–61, 2004. View at Google Scholar · View at Scopus
  42. G. Fadda, G. Campus, and P. Lugliè, “Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy,” BMC Oral Health, vol. 6, article 13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. World Health Organization, Handbook For Reporting Results of Cancer Treatment, World Health Organization, Geneva, Switzerland, 1979.
  44. S. T. Sonis, L. S. Elting, D. Keefe et al., “Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients,” Cancer, vol. 100, no. 9, pp. 1995–2025, 2004. View at Google Scholar · View at Scopus
  45. E. B. Rubenstein, D. E. Peterson, M. Schubert et al., “Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.,” Cancer, vol. 100, pp. 2026–2046, 2004. View at Google Scholar
  46. W. J. Köstler, M. Hejna, C. Wenzel, and C. C. Zielinski, “Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment,” CA—A Cancer Journal for Clinicians, vol. 51, no. 5, pp. 290–315, 2001. View at Google Scholar · View at Scopus
  47. C. E. Saadeh, “Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment,” Pharmacotherapy, vol. 25, no. 4, pp. 540–554, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Karthaus, C. Rosenthal, and A. Ganser, “Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis—are there new strategies?” Bone Marrow Transplantation, vol. 24, no. 10, pp. 1095–1108, 1999. View at Google Scholar · View at Scopus
  49. M. A. Huber and G. T. Terezhalmy, “The medical oncology patient,” Quintessence International, vol. 36, no. 5, pp. 383–402, 2005. View at Google Scholar · View at Scopus
  50. J. B. Epstein and M. M. Schubert, “Oropharyngeal mucositis in cancer therapy:Review of pathogenesis, diagnosis, and management,” Oncology, vol. 17, no. 12, pp. 1767–1779, 2003. View at Google Scholar · View at Scopus
  51. J. Crawford, D. C. Dale, and G. H. Lyman, “Chemotherapy-induced neutropenia, risks, consequences, and new directions for their management,” Cancer, vol. 100, pp. 228–237, 2004. View at Google Scholar
  52. A. Heimdahl, “Prevention and management of oral infections in cancer patients,” Supportive Care in Cancer, vol. 7, no. 4, pp. 224–228, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. J. B. Epstein and A. W. Chow, “Oral complications associated with immunosuppression and cancer therapies,” Infectious Disease Clinics of North America, vol. 13, no. 4, pp. 901–923, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Glick and M. A. Siegel, “Viral and fungal infections of the oral cavity in immunocompetent patients,” Infectious Disease Clinics of North America, vol. 13, no. 4, pp. 817–831, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. M. T. Montgomery, S. W. Redding, and C. F. LeMaistre, “The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy,” Oral Surgery Oral Medicine and Oral Pathology, vol. 61, no. 3, pp. 238–242, 1986. View at Google Scholar · View at Scopus
  56. I. T.-L. Tang and D. H. Shepp, “Herpes simplex virus infection in cancer patients: prevention and treatment,” Oncology, vol. 6, no. 7, pp. 101–109, 1992. View at Google Scholar · View at Scopus
  57. J. B. Epstein, C. Sherlock, J. L. Page, J. Spinelli, and G. Phillips, “Clinical study of herpes simplex virus infection in leukemia,” Oral Surgery Oral Medicine and Oral Pathology, vol. 70, no. 1, pp. 38–43, 1990. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Reusser, “Current concepts and challenges in the prevention and treatment of viral infections in immunocompromised cancer patients,” Supportive Care in Cancer, vol. 6, no. 1, pp. 39–45, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. P. B. Lockhart and S. T. Sonis, “Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy,” Oral Surgery Oral Medicine and Oral Pathology, vol. 48, no. 1, pp. 21–28, 1979. View at Google Scholar · View at Scopus
  60. J. A. Caprini and S. F. Sener, “Altered coagulability in cancer patients,” CA—A Cancer Journal for Clinicians, vol. 32, no. 3, pp. 162–172, 1982. View at Google Scholar · View at Scopus
  61. J. J. Sciubba and D. Goldenberg, “Oral complications of radiotherapy,” The Lancet Oncology, vol. 7, no. 2, pp. 175–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Herrstedt, “Prevention and management of mucositis in patients with cancer,” International Journal of Antimicrobial Agents, vol. 16, no. 2, pp. 161–163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. K. L. Mossman, “Quantitative radiation dose-response relationships for normal tissues in man. II. Response of the salivary glands during radiotherapy,” Radiation Research, vol. 95, no. 2, pp. 392–398, 1983. View at Google Scholar · View at Scopus
  64. K. Mossman, A. Shatzman, and J. Chencharick, “Long-term effects of radiotherapy on taste and salivary function in man,” International Journal of Radiation Oncology Biology Physics, vol. 8, no. 6, pp. 991–997, 1982. View at Google Scholar · View at Scopus
  65. P. Kaplan, “Mantle irradiation of the major salivary glands,” The Journal of Prosthetic Dentistry, vol. 54, no. 5, pp. 681–686, 1985. View at Google Scholar · View at Scopus
  66. P. J. Hughes, P. M. Scott, J. Kew et al., “Dysphagia in treated nasopharyngeal cancer,” Head & Neck, vol. 22, no. 4, pp. 393–397, 2000. View at Google Scholar
  67. V. Ramirez-Amador, S. Silverman Jr., P. Mayer, M. Tyler, and J. Quivey, “Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 84, no. 2, pp. 149–153, 1997. View at Google Scholar · View at Scopus
  68. M. S. Kies, D. J. Haraf, F. Rosen et al., “Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer,” Journal of Clinical Oncology, vol. 19, no. 7, pp. 1961–1969, 2001. View at Google Scholar · View at Scopus
  69. J. W. Schweiger, “Oral complications following radiation therapy: a five-year retrospective report,” The Journal of Prosthetic Dentistry, vol. 58, no. 1, pp. 78–82, 1987. View at Google Scholar · View at Scopus
  70. I. D. Mandel, “The role of saliva in maintaining oral homeostasis,” The Journal of the American Dental Association, vol. 119, no. 2, pp. 298–304, 1989. View at Google Scholar · View at Scopus
  71. A. Eisbruch, H. M. Kim, J. E. Terrell, L. H. Marsh, L. A. Dawson, and J. A. Ship, “Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer,” International Journal of Radiation Oncology Biology Physics, vol. 50, no. 3, pp. 695–704, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. J. M. Roesink, A. W. T. Konings, C. H. J. Terhaard, J. J. Battermann, H. H. Kampinga, and R. P. Coppes, “Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: radiation dose dependency and compensatory mechanisms,” International Journal of Radiation Oncology Biology Physics, vol. 45, no. 2, pp. 483–489, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. S. R. Porter, C. Scully, and A. M. Hegarty, “An update of the etiology and management of xerostomia,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 97, no. 1, pp. 28–46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. M. S. Chambers, A. S. Garden, M. S. Kies, and J. W. Martin, “Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management,” Head and Neck, vol. 26, no. 9, pp. 796–807, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. N. Andrews and C. Griffiths, “Dental complications of head and neck radiotherapy: Part 1,” Australian Dental Journal, vol. 46, no. 2, pp. 88–94, 2001. View at Google Scholar · View at Scopus
  76. A. D. Conger, “Loss and recovery of taste acuity in patients irradiated to the oral cavity,” Radiation Research, vol. 53, no. 2, pp. 338–347, 1973. View at Google Scholar · View at Scopus
  77. R. R. Million, “The effect of radiation on normal tissues of the head and neck,” in Management of Head and Neck Cancer: a Multidisciplinary Approach, N. J. Cassisi, Ed., J. P. Lippincott, Philadelphia, Pa, USA, 1984. View at Google Scholar
  78. L. R. Brown, S. Dreizen, S. Handler, and D. A. Johnston, “Effect of radiation induced xerostomia on human oral microflora,” Journal of Dental Research, vol. 54, no. 4, pp. 740–750, 1975. View at Google Scholar · View at Scopus
  79. C. Scully, J. Epstein, and S. Sonis, “Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis,” Head and Neck, vol. 26, no. 1, pp. 77–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Dreizen, “Description and incidence of oral complications,” NCI Monographs, no. 9, pp. 11–15, 1990. View at Google Scholar · View at Scopus
  81. R. E. Marx, “Osteoradionecrosis: a new concept of its pathophysiology,” Journal of Oral and Maxillofacial Surgery, vol. 41, no. 5, pp. 283–288, 1983. View at Google Scholar · View at Scopus
  82. J. Beumer III, S. Silverman Jr., and S. B. Benak Jr., “Hard and soft tissue necroses following radiation therapy for oral cancer,” The Journal of Prosthetic Dentistry, vol. 27, no. 6, pp. 640–644, 1972. View at Google Scholar · View at Scopus
  83. J. B. Epstein, G. Rea, F. L. W. Wong, J. Spinelli, and P. Stevenson-Moore, “Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy,” Head and Neck Surgery, vol. 10, no. 1, pp. 48–54, 1987. View at Google Scholar · View at Scopus
  84. T. Reuther, T. Schuster, U. Mende, and A. C. Kübler, “Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients—a report of a thirty year retrospective review,” International Journal of Oral and Maxillofacial Surgery, vol. 32, no. 3, pp. 289–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. G. Studer, K. W. Grätz, and C. Glanzmann, “Osteoradionecrosis of the Mandibula in Patients Treated with Different Fractionations,” Strahlentherapie und Onkologie, vol. 180, no. 4, pp. 233–240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Beumer III, T. Curtis, and R. E. Harrison, “Radiation therapy of the oral cavity: sequelae and management, Part I,” Head and Neck Surgery, vol. 1, no. 4, pp. 301–312, 1979. View at Google Scholar · View at Scopus
  87. W. K. Collett and J. C. Thonard, “The effect of fractional radiation on dentinogenesis in the rat,” Journal of Dental Research, vol. 44, pp. 84–90, 1965. View at Google Scholar · View at Scopus
  88. H. S. Koppang, “Studies on the radiosensitivity of the rat incisor,” Odontologisk Tidskrift, vol. 75, no. 5, pp. 413–450, 1967. View at Google Scholar · View at Scopus
  89. A. Vissink, J. Jansma, F. K. L. Spijkervet, F. R. Burlage, and R. P. Coppes, “Oral sequelae of head and neck radiotherapy,” Critical Reviews in Oral Biology and Medicine, vol. 14, no. 3, pp. 199–212, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. F. Thomas, F. Ozanne, G. Mamelle, P. Wibault, and F. Eschwege, “Radiotherapy alone for oropharyngeal carcinomas: the role of fraction size (2 Gy vs 2.5 Gy) on local control and early and late complications,” International Journal of Radiation Oncology Biology Physics, vol. 15, no. 5, pp. 1097–1102, 1988. View at Google Scholar · View at Scopus
  91. R. Steelman and J. Sokol, “Quantification of trismus following irradiation of the temporomandibular joint,” Missouri Dental Journal, vol. 66, no. 6, pp. 21–23, 1986. View at Google Scholar · View at Scopus
  92. C.-J. Wang, E.-Y. Huang, H.-C. Hsu, H.-C. Chen, F.-M. Fang, and C.-Y. Hsiung, “The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer,” Laryngoscope, vol. 115, no. 8, pp. 1458–1460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. D. Eisen, J. Essell, and E. R. Broun, “Oral cavity complications of bone marrow transplantation,” Seminars in Cutaneous Medicine and Surgery, vol. 16, no. 4, pp. 265–272, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Barasch and M. M. Safford, “Management of oral pain in patients with malignant diseases,” Compendium, vol. 14, no. 11, pp. 1376–1386, 1993. View at Google Scholar · View at Scopus
  95. R. Collins, G. W. Miller, and J. W. Fay, “Autologous bone marrow transplantation: a review,” BUMC Proceedings, vol. 4, no. 2, pp. 3–12, 1991. View at Google Scholar
  96. W. G. Maxymiw and R. E. Wood, “The role of dentistry in patients undergoing bone marrow transplantation,” British Dental Journal, vol. 167, no. 7, pp. 229–234, 1989. View at Google Scholar · View at Scopus
  97. A. P. Barrett and M. Schifter, “Antibiotic strategy in orofacial/head and neck infections in severe neutropenia,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 77, no. 4, pp. 350–355, 1994. View at Google Scholar · View at Scopus
  98. T. Mattsson, A. Heimdahl, G. Dahllof, B. Lonnquist, and O. Ringden, “Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft- versus-host disease,” Oral Surgery Oral Medicine and Oral Pathology, vol. 74, no. 1, pp. 34–40, 1992. View at Publisher · View at Google Scholar · View at Scopus
  99. B. B. Toth, J. W. Martin, M. S. Chambers, K. A. Robinson, and B. S. Andersson, “Oral candidiasis: a morbid sequela of anticancer therapy,” Texas Dental Journal, vol. 115, no. 6, pp. 24–29, 1998. View at Google Scholar · View at Scopus
  100. A. T. Brown, J. A. Shupe, R. E. Sims et al., “In vitro effect of chlorhexidine and amikacin on oral gram-negative bacilli from bone marrow transplant recipients,” Oral Surgery Oral Medicine and Oral Pathology, vol. 70, no. 6, pp. 715–719, 1990. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Birek, B. Patterson, W. C. Maximiw, and M. D. Minden, “EBV and HSV infections in a patient who had undergone bone marrow transplantation: oral manifestations and diagnosis by in situ nucleic acid hybridization,” Oral Surgery Oral Medicine and Oral Pathology, vol. 68, no. 5, pp. 612–617, 1989. View at Google Scholar · View at Scopus
  102. F. G. LeVeque, V. Ratanatharathorn, M. E. Dan, B. Orville, D. N. Coleman, and S. Turner, “Oral cytomegalovirus infection in an unrelated bone marrow transplantation with possible mediation by graft-versus-host disease and the use of cyclosporin-A,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 77, no. 3, pp. 248–253, 1994. View at Google Scholar · View at Scopus
  103. M. M. Schubert, D. E. Peterson, N. Flournoy, J. D. Meyers, and E. L. Truelove, “Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection,” Oral Surgery Oral Medicine and Oral Pathology, vol. 70, no. 3, pp. 286–293, 1990. View at Google Scholar · View at Scopus
  104. L. M. Schuchter, J. R. Wingard, S. Piantadosi, W. H. Burns, G. W. Santos, and R. Saral, “Herpes zoster infection after autologous bone marrow transplantation,” Blood, vol. 74, no. 4, pp. 1424–1427, 1989. View at Google Scholar · View at Scopus
  105. J. M. Vose, B. C. Kennedy, P. J. Bierman, A. Kessinger, and J. O. Armitage, “Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies,” Cancer, vol. 69, no. 3, pp. 784–789, 1992. View at Google Scholar · View at Scopus
  106. M. M. Schubert, J. B. Epstein, M. E. Lloid, and E. Cooney, “Oral infections due to Cytomegalovirus in immunocompromised patients,” Journal of Oral Pathology and Medicine, vol. 22, no. 6, pp. 268–273, 1993. View at Google Scholar · View at Scopus
  107. J. B. Epstein, C. H. Sherlock, and R. A. Wolber, “Hairy leukoplakia after bone marrow transplantation,” Oral Surgery Oral Medicine and Oral Pathology, vol. 75, no. 6, pp. 690–695, 1993. View at Google Scholar · View at Scopus
  108. B. B. Toth, M. S. Chambers, T. J. Fleming, J. C. Lemon, and J. W. Martin, “Minimizing oral complications of cancer treatment,” Oncology, vol. 9, no. 9, pp. 851–866, 1995. View at Google Scholar · View at Scopus
  109. B. B. Toth, M. S. Chambers, and T. C. Fleming, “Prevention and management of oral complications associated with cancer therapies: radiotherapy/chemotherapy,” Texas Dental Journal, vol. 113, no. 6, pp. 23–29, 1996. View at Google Scholar · View at Scopus
  110. D. E. Peterson, “Pretreatment strategies for infection prevention in chemotherapy patients,” NCI Monographs, no. 9, pp. 61–71, 1990. View at Google Scholar · View at Scopus
  111. S. A. Fayle, M. S. Duggal, and S. A. Williams, “Oral problems and the dentist's role in the management of paediatric oncology patients,” Dental Update, vol. 19, no. 4, pp. 152–158, 1992. View at Google Scholar · View at Scopus
  112. K. M. Sullivan, H. J. Deeg, and J. Sanders, “Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation,” Blood, vol. 67, no. 4, pp. 1172–1175, 1986. View at Google Scholar · View at Scopus
  113. E. Tivol, R. Komorowski, and W. R. Drobyski, “Emergent autoimmunity in graft-versus-host disease,” Blood, vol. 105, no. 12, pp. 4885–4891, 2005. View at Publisher · View at Google Scholar · View at Scopus
  114. A. E. Chang, D. F. Hayes, H. I. Pass et al., Oncology: an Evidence-Based Approach, Springer, New York, NY, USA, 2006.
  115. K. K.-F. Cheng, “Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy,” Journal of Clinical Nursing, vol. 16, no. 11, pp. 2114–2121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. A. Chan and R. J. Ignoffo, “Survey of topical oral solutions for the treatment of chemo-induced oral mucositis,” Journal of Oncology Pharmacy Practice, vol. 11, no. 4, pp. 139–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. D. M. Keefe, M. M. Schubert, L. S. Elting et al., “Updated clinical practice guidelines for the prevention and treatment of mucositis,” Cancer, vol. 109, no. 5, pp. 820–831, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. R. Spielberger, P. Stiff, W. Bensinger et al., “Palifermin for oral mucositis after intensive therapy for hematologic cancers,” The New England Journal of Medicine, vol. 351, no. 25, pp. 2590–2598, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. E. Schmidt, N. H. Thoennissen, A. Rudat et al., “Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis,” Annals of Oncology, vol. 19, no. 9, pp. 1644–1649, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Vadhan-Raj, J. Trent, S. Patel et al., “Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial,” Annals of Internal Medicine, vol. 153, no. 6, pp. 358–367, 2010. View at Google Scholar · View at Scopus
  121. R. V. Lalla, S. T. Sonis, and D. E. Peterson, “Management of Oral Mucositis in Patients Who Have Cancer,” Dental Clinics of North America, vol. 52, no. 1, pp. 61–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  122. G. B. L. Silva, E. F. Mendonça, C. Bariani, H. S. Antunes, and M. A. G. Silva, “The prevention of induced oral mucositis with low-level laser therapy in bone marrow transplantation patients: a randomized clinical trial,” Photomedicine and Laser Surgery, vol. 29, no. 1, pp. 27–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. J. E. Noé, “L-glutamine use in the treatment and prevention of mucositis and cachexia: a naturopathic perspective,” Integrative Cancer Therapies, vol. 8, no. 4, pp. 409–415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. D. E. Peterson, J. B. Jones, and R. G. Petit II, “Randomized, placebo-controlled trial of saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy,” Cancer, vol. 109, no. 2, pp. 322–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. I. Sukhotnik, J. G. Mogilner, R. Karry et al., “Effect of oral glutamine on enterocyte turnover during methotrexate-induced mucositis in rats,” Digestion, vol. 79, no. 1, pp. 5–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. I. Sukhotnik, J. G. Mogilner, D. Shteinberg et al., “Leptin accelerates enterocyte turnover during methotrexate-induced intestinal mucositis in a rat,” Cancer Biology and Therapy, vol. 8, no. 10, pp. 899–906, 2009. View at Google Scholar · View at Scopus
  127. R. Rautemaa, A. Lauhio, M. P. Cullinan, and G. J. Seymour, “Oral infections and systemic disease—an emerging problem in medicine,” Clinical Microbiology and Infection, vol. 13, no. 11, pp. 1041–1047, 2007. View at Publisher · View at Google Scholar · View at Scopus
  128. R. V. Lalla, M. C. Latortue, C. H. Hong et al., “A systematic review of oral fungal infections in patients receiving cancer therapy,” Supportive Care in Cancer, vol. 18, no. 8, pp. 985–992, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. H. V. Worthington, J. E. Clarkson, T. Khalid, S. Meyer, and M. McCabe, “Interventions for treating oral candidiasis for patients with cancer receiving treatment,” Cochrane Database of Systematic Reviews), vol. 7, p. CD001972, 2010. View at Google Scholar · View at Scopus
  130. P. G. Pappas, C. A. Kauffman, D. Andes et al., “Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 48, no. 5, pp. 503–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. J. F. G. M. Meis and P. E. Verweij, “Current management of fungal infections,” Drugs, vol. 61, no. 1, pp. 13–25, 2001. View at Google Scholar · View at Scopus
  132. J. A. Vazquez, “Invasive oesophageal candidiasis: current and developing treatment options,” Drugs, vol. 63, no. 10, pp. 971–989, 2003. View at Publisher · View at Google Scholar · View at Scopus
  133. C. D. Collins, J. J. Ellis, and D. R. Kaul, “Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia,” American Journal of Health-System Pharmacy, vol. 65, no. 23, pp. 2237–2243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. W. Schonfeld, J. Wang Cheng, K. B. Tong, and R. Seifeldin, “Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation,” Clinical Therapeutics, vol. 30, no. 5, pp. 964–973, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. W. B. Stam, A. K. O'Sullivan, B. Rijnders et al., “Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands,” European Journal of Haematology, vol. 81, no. 6, pp. 467–474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. H. S. Sohn, T.-J. Lee, J. Kim, and D. Kim, “Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea,” Clinical Therapeutics, vol. 31, no. 5, pp. 1105–1115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. R. De La Cámara, I. Jarque, M. A. Sanz et al., “Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT,” Bone Marrow Transplantation, vol. 45, no. 5, pp. 925–932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  138. S. Elad, Y. Zadik, I. Hewson et al., “A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea,” Supportive Care in Cancer, vol. 18, no. 8, pp. 993–1006, 2010. View at Publisher · View at Google Scholar · View at Scopus
  139. A.-M. Glenny, L. M. Fernandez Mauleffinch, S. Pavitt, and T. Walsh, “Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD006706, 2009. View at Google Scholar · View at Scopus
  140. P. Reusser, “Management of viral infections in immunocompromised cancer patients,” Swiss Medical Weekly, vol. 132, no. 27-28, pp. 374–378, 2002. View at Google Scholar · View at Scopus
  141. P. G. Arduino and S. R. Porter, “Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management,” Oral Diseases, vol. 12, no. 3, pp. 254–270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  142. S. Chilukuri and T. Rosen, “Management of acyclovir-resistant herpes simplex virus,” Dermatologic Clinics, vol. 21, no. 2, pp. 311–320, 2003. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Syrjanen, P. Laine, M. Niemela, and R.-P. Happonen, “Oral hairy leukoplakia is not a specific sign of HIV-infection but related to immunosuppression in general,” Journal of Oral Pathology and Medicine, vol. 18, no. 1, pp. 28–31, 1989. View at Google Scholar · View at Scopus
  144. H.-H. Cho, S.-H. Kim, S.-H. Seo et al., “Oral hairy leukoplakia which occurred as a presenting sign of acute myeloid leukemia in a child,” Annals of Dermatology, vol. 22, no. 1, pp. 73–76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. J. Blomgren and H. Bäck, “Oral hairy leukoplakia in a patient with multiple myeloma,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 82, no. 4, pp. 408–410, 1996. View at Google Scholar · View at Scopus
  146. O. Nicolatou, G. Nikolatos, M. Fisfis et al., “Oral hairy leukoplakia in a patient with acute lymphocytic leukemia,” Oral Diseases, vol. 5, no. 1, pp. 76–79, 1999. View at Google Scholar · View at Scopus
  147. E. Piperi, J. Omlie, I. G. Koutlas, and S. Pambuccian, “Oral hairy leukoplakia in HIV-negative patients: report of 10 cases,” International Journal of Surgical Pathology, vol. 18, no. 3, pp. 177–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. D. M. Walling, C. M. Flaitz, and C. M. Nichols, “Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir,” Journal of Infectious Diseases, vol. 188, no. 6, pp. 883–890, 2003. View at Publisher · View at Google Scholar · View at Scopus
  149. M. D. G. Moura, T. R. M. Guimarães, L. M. S. Fonseca, I. de Almeida Pordeus, and R. A. Mesquita, “A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 103, no. 1, pp. 64–71, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. M. D. G. Moura, J. P. A. Haddad, M. I. B. Senna, E. Ferreira E Ferreira, and R. A. Mesquita, “A new topical treatment protocol for oral hairy leukoplakia,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 110, no. 5, pp. 611–617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  151. S. S. Bhandarkar, J. MacKelfresh, L. Fried, and J. L. Arbiser, “Targeted therapy of oral hairy leukoplakia with gentian violet,” Journal of the American Academy of Dermatology, vol. 58, no. 4, pp. 711–712, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. B. J. Cowart, “Taste dysfunction: a practical guide for oral medicine,” Oral Diseases, vol. 17, no. 1, pp. 2–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  153. A. J. Hovan, P. M. Williams, P. Stevenson-Moore et al., “A systematic review of dysgeusia induced by cancer therapies,” Supportive Care in Cancer, vol. 18, no. 8, pp. 1081–1087, 2010. View at Publisher · View at Google Scholar · View at Scopus
  154. M. Y. Halyard, “Taste and smell alterations in cancer patients—real problems with few solutions,” Journal of Supportive Oncology, vol. 7, no. 2, pp. 68–69, 2009. View at Google Scholar · View at Scopus
  155. M. Fink, “Vitamin D deficiency is a cofactor of chemotherapy-induced mucocutaneous toxicity and dysgeusia,” Journal of Clinical Oncology, vol. 29, no. 4, pp. e81–e82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. P. Ravasco, I. Monteiro-Grillo, P. M. Vidal, and M. E. Camilo, “Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy,” Head and Neck, vol. 27, no. 8, pp. 659–668, 2005. View at Publisher · View at Google Scholar · View at Scopus
  157. P. Ravasco, I. Monteiro-Grillo, P. M. Vidal, and M. E. Camilo, “Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy,” Journal of Clinical Oncology, vol. 23, no. 7, pp. 1431–1438, 2005. View at Publisher · View at Google Scholar · View at Scopus